Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Integrated positron emission tomography-computed tomography"
Filter
Filter
Article type
Keywords
Publication year
Authors
Review Article
Adrenal gland
Differential Diagnosis of Adrenal Mass Using Imaging Modality: Special Emphasis on F-18 Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography
Hong Je Lee, Jaetae Lee
Endocrinol Metab. 2014;29(1):5-11.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.5
  • 4,105 View
  • 30 Download
  • 7 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   

Adrenal incidentalomas are adrenal masses serendipitously detected during an imaging study performed for reasons unrelated to suspicion of adrenal disease. The incidence of adrenal incidentalomas has increased because of the widespread use of various imaging modalities. In oncology patients with adrenal incidentalomas, the characterization of the adrenal masses is challenging because nearly 50% of incidental adrenal masses are metastatic lesions that need special medical attention. Although unenhanced computed tomography (CT) densitometry, chemical shift magnetic resonance imaging (MRI), delayed contrast-enhanced CT and CT histogram analysis have been used as sensitive and specific modalities for differentiating benign from malignant adrenal masses, F-18 fluoro-2-deoxy-D-glucose positron emission tomography (F-18 FDG PET)/CT is a highly accurate imaging modality compared to CT or MRI, especially when these two imaging modalities are combined. In addition, a semiquantitative analysis using standardized uptake value ratio further improves the diagnostic accuracy of F-18 FDG PET/CT in differentiating benign from malignant adrenal masses. Thus, F-18 FDG PET/CT is very helpful for determining the best therapeutic management, especially for assessing the need for surgery.

Citations

Citations to this article as recorded by  
  • The F-18 FDG PET/CT evaluation of the metastatic adrenal lesions of the non-lung cancer tumors compared with pathology results
    Zehra Pınar Koç, Pınar Pelin Özcan, Emel Sezer, Kadir Eser, Tuba Kara
    Egyptian Journal of Radiology and Nuclear Medicine.2022;[Epub]     CrossRef
  • Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions
    Hussein Farghaly, Mohamed Alshareef, Abdullah Alqarni, Mohamed Sayed, Hatem Nasr
    European Journal of Radiology Open.2020; 7: 100268.     CrossRef
  • 18F-FDG PET/CT Imaging of Adrenal Liposarcoma
    Rang Wang, Qiuping Fan, Rong Tian
    Clinical Nuclear Medicine.2020; 45(7): 570.     CrossRef
  • Characterization of adrenocortical tumors by 18F-FDG PET/CT: Does steroid hormone hypersecretion status modify the uptake pattern?
    Nunzia Cinzia Paladino, Carole Guérin, Aoïfe Lowery, Andrea Attard, Wassim Essamet, Eveline Slotema, Isabelle Morange, Frédéric Castinetti, Thierry Brue, Anderson Loundou, David Taïeb, Frédéric Sebag
    Surgical Oncology.2018; 27(2): 231.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Adrenal masses in oncology patients
    Rodney H Reznek
    Cancer Imaging.2014;[Epub]     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism